CareDx CareDx Receives CE Mark for Hematopoietic Cell Transplantation Testing Kit, Analysis Software The designation furthers the firm's expansion into the stem cell transplant space, which began with the launch of AlloCell in 2020. Natera Files New Patent Infringement Lawsuit Against CareDx Natera alleges that several of CareDx's organ transplant products infringe the patent underlying its Panorama NIPT assay. CareDx Q1 Revenues up 18 Percent The firm said March was its highest ever month of testing volume for its heart and kidney transplant testing services. Natera Adds Clinical Utility Evidence for Cell-Free DNA in Allograft Health Premium Three new studies focusing on the heart, lungs, and kidneys add to a growing body of evidence in support of donor-derived cell-free DNA as an organ health measure. In Brief This Week: Biocept, SeqLL, Castle Biosciences, VolitionRx, More News items for the week of March 28, 2022. Mar 25, 2022 New Products Posted to GenomeWeb: Miroculus, Oxford Nanopore, CareDx, More Mar 15, 2022 Jury Awards CareDx $44.9M in Natera Lawsuit; Finds Both Companies Engaged in False Advertising Feb 24, 2022 CareDx Q4 Revenues Rise 35 Percent Jan 21, 2022 CareDx Prepares KidneyCare for Commercial Launch With CLIA Validation, Clinical Studies Premium Jan 10, 2022 CareDx, Castle Bio, Lucira Health, Others Announce Preliminary Q4, FY21 Earnings Results Dec 13, 2021 CareDx to Study AlloSure Kidney for Routine Organ Transplant Surveillance in Pediatric Patients Nov 12, 2021 In Brief This Week: Caris Life Sciences, Psomagen, Tempus, CareDx, HTG Molecular, Epigenomics, More Nov 1, 2021 GenomeWeb Index Bounces Back in October, Led by Rebound in Berkeley Lights Stock Oct 29, 2021 CareDx Works Toward Goal of Becoming Essential Transplant Diagnostics Company Premium Oct 28, 2021 CareDx Q3 Revenues Grow 42 Percent; Firm Discloses Investigations by DOJ, SEC Sep 29, 2021 CareDx Patents Deemed Invalid in Court Battle Against Natera, Eurofins Viracor Sep 1, 2021 GenomeWeb Index up Slightly in August as Guardant Health Leads on Strength of Q2 Earnings Jul 29, 2021 CareDx Q2 Revenues up 77 Percent Jun 8, 2021 CareDx Acquires App Developer Transplant Hero May 5, 2021 CareDx Q1 Revenues up 76 Percent Apr 22, 2021 Medicare Administrative Contractor Palmetto Finalizes Coverage of Molecular Testing for Organ Transplant Rejection Apr 9, 2021 New Products Posted to GenomeWeb: Qiagen, CareDx, Synthego, More Apr 2, 2021 People in the News: New Appointments at CareDx, BioSkryb, Oxford Nanopore, More Mar 17, 2021 CareDx Acquires European Transplant Surveillance Software Firm BFS Molecular Feb 25, 2021 CareDx Expanding Diagnostic Tech Into Cell Transplant Monitoring Premium Load More Breaking News Becton Dickinson Gets CE-IVD Mark for High-Throughput COVID/Flu PCR Test QuantuMDx Obtains CE Mark for 30-Minute Multiplex Respiratory Panel Mitochondrial Protein Resource Reveals New Disease Players StageZero Life Sciences, DiagnoseAtHome Partner on Multicancer Blood Test OraSure Technologies Selected by HHS to Provide COVID-19 School Testing Hologic Obtains CE Mark for Molecular Epstein-Barr, BK Virus Assays The Scan UK Moves to Allow Sale of Gene-Edited Food The UK is moving ahead to allow the sale of gene-edited food in England, Scotland, and Wales, according to New Scientist. Questions for the Field Stat News writes that the alleged Buffalo shooter's citation of genetics research raises questions about what the field can do. Cell Studies on Tumor Evolution in Mouse Model of Lung Cancer, Stereo-seq, Bacteriophage Responses In Cell this week: tumor evolution tracked in mouse model of lung cancer, organogenesis mapped using Stereo-seq, and more. Taking Stock of the Stockpile The US and European countries are evaluating their smallpox vaccine stockpiles as the number of monkeypox cases increases, the Washington Post reports.